Genindex-prodindex.xls
SUBJECT TITLE
VOLUME NO
ACETAZOLAMIDE TABS - FUNGAL CONTAMINATION
ADMINISTRATION -RESPONSIBILITIES FOR SAFE
ADRENALINE - PACKAGING OF PRE-FILLED SYRINGES
ALFACALCIDOL - LABELLING AND OVERDOSE INCIDENTS
ALUMINIUM CONTAMINATION OF CALCIUM GLUCONATE
AMPHOTERICIN - SOLUTION ON RECONSTITUTION
ANAESTHETIC MACHINES AND OXYGEN ANALYSERS
ASCORBIC ACID - NON PL TABLETS POOR QUALITY
ASEPTIC PREPARATION - FINAL CHECKING ISSUES
ASPARAGINASE - PARTICLES AFTER RECONSTITUTION
ATROPHINE - ADRENALINE SYRINGE IN CRASH BOX
BENADRYL - CONFUSION OF ACTIVE INGREDIENTS
BETAMETHASONE - INCOMPATIBILITY WITH COAL TAR
BETAMETHASONE EYE DROPS - USE AFTER OPENING
BRAND NAMES - CONFUSION OF ACTIVE INGREDIENTS
BUDESONIDE (PULMICORT RESPULES) LABELLING
CANCER CHEMOTHERAPY: FOR BETTER FOR WORSE REPORT
CHLORMETHIAZOLE SYRUP - STORAGE TEMPERATURE
CIPROFLOXACIN SUSPENSION - LABELLING ISSUES
CLINICAL TRIALS - IMPLEMENTATION OF EC DIRECTIVE
CLINOMEL - CONTENTS MIXING BEFORE INTENDED USE
CLINOMEL - CONTENTS MIXING BEFORE INTENDED USE
CO-CARELDOPA TABS - DOWELHURST PARALLEL IMPORT
COLD CHAIN MONITORING/FRIDGE TEMPERATURES
COLOMYCIN - SHELF LIFE AFTER RECONSTITUTION
COMPLIANCE ISSUES LABELLING & PACKAGING
COMPLIMENTARY AND NATURAL HEALTHCARE COUNCIL
CONTACT LENS SOLNS - ACANTHAMOEBA KERATITIS
COTRIMOXAZOLE - PRECIPITATION OF INJECTION
COUNSELLING - CODE OF ETHICS REQUIREMENTS
CYCLOPENTOLATE EYE DROPS - PACKAGING PROBLEMS
CYCLOPHOSPHAMIDE - RECONSTITUTION DIRECTIONS
CYTARABINE INJECTION - STRENGTH CONFUSIONS
CYTOTOXIC DRUGS - HEALTH AND SAFETY ISSUES
DIPHTHERIA VACCINE - EXPIRY DATE CONFUSION
DIPTHERIA & TETANUS VACCINE - LABELLING
DISCONTINUED MEDICINES - BEST PRACTICE GUIDELINES
DOXORUBICIN - DILUENT FOR RECONSITITUTION
ERTHROMYCIN SUSPENSION - VOLUME AFTER RECONSTITUTIO
ETOMIDATE - POTENTIAL MIX-UP WITH PROPOFOL
EXTEMPORANEOUS DISPENSING - YELLOW COVERED DOCUME
FLECAINIDE INJ - GLASS FRAGMENTS WHEN AMPS OPENED
FLUCLOXACILLIN SYRUP - FAILURE TO DISSOLVE
FLUPHENAZONE INJECTION LABELLING CONFUSION
FLUROURACIL - MORE REPORTS OF CRYSTAL PRESENT
FRESUBIN EASY BAGS - MICROBIAL CONTAMINATION
FRESUBIN EASY BAGS - MICROBIAL CONTAMINATION
GELOFUSINE - DIFFICULTIES WITH GIVING SETS & LEAKING BAG
GEMCITABINE - RECONSTITUTION INSTRUCTIONS
GENERICS - MODIFIED RELEASE PREPARATIONS
HAZARDS/RISKS IN DISPENSARIES (EDITORIAL)
HEARING AID LOOP SYSTEM - N&N HOSPITAL
HUMAN IMMUNOGLOBULIN - RECONSTITION PROBLEMS
INFUSION BAGS - WATER LOSS DURING STORAGE
INFUSIONS - PLASTIC PARTICLES CONTAMINATION
INJECTIONS - LABELLING OF SYRINGES IN THEATRES
INJECTIONS - PREPARATION IN CLINICAL AREAS
INNOVATIONS - ALTERNATIVE TO FREEZE DRYING
INTRATHECAL INJECTIONS INVOLVING CHEMOTHERAPY
ISOSORBIDE MONONITRATE - LABEL DEFECT/RECALL
LABELLING AND PACKAGING - CSM WORKING GROUP
LEAFLETS - PILs NOT AVAILABLE FOR SOME PRODUCTS
LICENCE ISSUES - IMPORTED DRUGS (EDITORIAL)
LIGNOCAINE DENTAL CARTRIDGES - STORAGE REQUIREMENTS
MAGNESIUM SULPHATE - EXPRESSION OF STRENGTH
MEDICAL DEVICE ALERTS - NEW GUIDANCE DOCUMENT
MEDICAL GASES - SAFETY ISSUES WITH MRI EQUIPMENT
MEDICAL GASES - TESTING PIPED GAS INSTALLATIONS
MEDICAL GASES - YELLOW COLOURATION OF FILTERS
MEDICATION ERRORS - LEARNING FROM MISTAKES
MEDICATION ERRORS - LOOK-ALIKE AND SOUND-ALIKE NAMES
MEDICATION ERRORS - MICROGRAM/MILLIGRAM CONFUSION
MEDICATION ERRORS - PACKAGING AND LABELLING ISSUES
MEDICINE HELPLINE - PETERBOROUGH HOSPITAL
MEDROXYPROGESTERONE INJ - EXTRACTABLE VOLUME
METHOTREXATE TABLETS - STRENGTH CONFUSION
METRONIDAZOLE - CONFUSION OF COMPATIBILITIES
METRONIDAZOLE - LABELLING OF SUPPOSITORIES
METRONIDAZOLE INJECTION - LABELLING CONFUSION
MICRO ORGANISMS - SURVIVAL IN HOSTILE ENVIRONMENTS
MITOMYCIN - SHELF LIFE AFTER RECONSTITUTION
MITOMYCIN - STABILITY AFTER RECONSTITUTION
NHS 50TH ANNIVERSARY - PATIENT ENPOWERMENT (EDITORIAL
NOMENCLATURE - NAME CONFUSION (EDITORIAL)
NORADRENALINE - LABELLING OF IMPORTED INJECTION
NOSOCOMIAL INFECTION AND CIVAS (EDITORIAL)
ONCOLOGY PHARMACY & CHEMOTHERAPY STANDARDISATION
ORGANOPHOSPHATE POISONING - PRALIDOXIME MESYLYTATE
OVERLABELLING - OBSCURING ESSENTIAL INFORMATION
PAPWORTH HOSPITAL - QUALITY IMPROVEMENT INITIATIVES
PATIENT PERCEPTIONS - SERVICE QUALITY (EDITORIAL)
PENTOSTAM, PENTOSAN, PENTOSTATIN NAME CONFUSION
PHENOL INJECTION IN ALMOND OIL - LABEL ISSUE
POTASSIUM CHLORIDE SOLN - DILUTION REQUIREMENTS
POVIDONE IODINE VAGINAL GEL - APPLICATOR PROBLEMS
PRESCRIBING FOR CHILDREN - OFF-LABEL ISSUES
PRESCRIPTION WRITING - LEGIBILITY/COMPUTERS
PROCHLORPERAZINE - TABLET COLOUR VARIATION
PRODUCT LICENCES/MARKETING AUTHORISATIONS NUMBERS
PROPOFOL - INCOMPATIBILITY WITH VYGON LINES
QUALITY MATTERS 100TH EDITION (EDITORIAL)
SAFETY - RSI AND OTHER OCCUPATIONAL HAZARDS
SALBUTAMOL - LABELLING OF BLOW FILL SEAL
SODIUM CHLORIDE - NORMOSOL SACHETS - CONCENTRATION
SODIUM CHLORIDE INJECTION - EXPRESSION OF STRENGTH
SODIUM CHLORIDE INJECTION - EXPRESSION OF STRENGTH
SODIUM CHLORIDE UROTAINERS - USER PROBLEMS
STANDARDS - PERVERSE INCENTIVES (EDITORIAL)
STAVUDINE ORAL SOLUTION - LABELLING CONFUSION
STERILE MANUFACTURE/PREPARATION OCCUPATIONAL
SYRINGE HUBS - LEAKING MULTI-ADD (BRAUN) BRAND
TEICOPLANIN - PRECIPITATION OF RECONSTITUTED INJECTION
TEICOPLANIN - STABILITY OF RECONSTITUTED INJECTION
TPN - ALGORITHM FOR FORMULATION STABILITY
TPN - INTRAVENOUS CATHETERS WITH NEONATES
UNLICENSED MEDICINES - LOCAL TRUST POLICIES
UNLICENSED MEDICINES - PATIENT AWARENESS ISSUES
UNLICENSED MEDICINES PATIENT AWARENESS OF STATUS
VALIDATION, CHANGE CONTROL & CAPACITY PLANNING
VERIFICATION OF CHEMOTHERAPY PRESCRIPTIONS
VINCA ALKALOIDS - DOH REPORT FOLLOWING NOTTINGHAM FAT
VINCRISTINE ADMINISTRATION GUIDELINES (EDITORIAL)
VIPER VENOM ANTISERUM - DOSE INSTRUCTIONS
Source: http://www.nhsped.uea.ac.uk/assets/v2/documents/genindex-prodindex.pdf
Press Release 50% women think a woman can have at least 2 sex partners in her lifetime Open-minded in sex yet lack sound contraception knowledge Specialist urges the adoption of contraceptives Hong Kong single women are increasingly open-minded on sex due to higher education, better job prospect, and stronger financial power. A survey conducted by the University of Hong Kong ha
Volume 373 · Number 9671 · April 11–17, 2009 The Lancet—London Editorial Articles 1253 Zoledronic acid and risedronate in the prevention and 1224 Care for vulnerable migrants in the UKtreatment of glucocorticoid-induced osteoporosis double-dummy, randomised controlled trial The Lancet—New York 1225 Glucocorticoid-induced osteoporosis: hope on the 1264
A |
B |C |
D |
E |F |
G |
H |
I |J |K |
L |
M |
N |
O |P |Q |
R |
S |
T |
U |V |W |
X |
Y |
Z |0-9 |